ANGO

ANGIODYNAMICS INC

Healthcare · Medical Instruments & Supplies

$15.24

−$0.08−0.52%

Delayed · 2026-09-10T20:00:00.000Z · marketstack

Price history unavailable

The chart could not be loaded for this symbol right now. The figures below are unaffected.

Day range51% of range

$15.01$15.46

Session

Source SEC EDGAR · 9/11/2026

Out of 137 passages in this year’s Item 1A.

The assistant has not been given these passages. It will say so, and say what opens them. This costs you no question.

New this year

ability to drive revenue growth, which could have a material adverse effect on our business, financial condition, results of operations and/or liquidity.

37 more passages, included withBespoke

From Item 1A of its most recent 10-K, filed July 2026.

And 22 more.

FDA approval
Our business and prospects rely heavily upon our ability to successfully complete clinical trials, including, but not limited to, our Ambition BTK clinical study. We may choose to, or may be required to, suspend, repeat or terminate our clinical trials if …

7 more themes, included withMeasure

14 more events, included withMeasure

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

See every investor holding ANGIODYNAMICS INC, and every quarter they moved.

Ten seconds, no card, and nothing to cancel.

No card, no broker connection.

Separate the decisions from the paperwork
Every Form 4 ANGO insiders have filed, with vesting and automatic tax sales struck out: what's left is the buys and sells somebody actually chose to make.
Every filingMeasure